Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphoma

  • Martín-Pérez, D.
  • Vargiu, P.
  • Montes-Moreno, Noemí
  • Andrés-León, Eduardo
  • Rodríguez-Pinilla, S. M.
  • Lisio, Lorena di
  • Martínez Martínez, Noelia
  • Rodríguez, R.
  • Mollejo, M.
  • Castellvi, J.
  • Pisano, David G.
  • Sánchez-Beato, M.
  • Piris, M. A.
We have studied the miRNA expression profile in 36 DLBCL samples using miRNA microarrays. Prevalence of EBV in this series (33 EBV-negative and 3 EBV-positive) was close to normal prevalence in DLBCL.1 Twenty-two out of thirty-two analysed viral miRNAs were significantly upregulated in EBV-positive samples (>two-fold change; t-test corrected P-value<0.05, Figure 1c, Supplementary table 2 and Supplementary table 3)., We would like to acknowledge all members of CNIOs Lymphoma Group for their thoughtful discussion. This study was funded with the following grants: from Ministerio de Educacio´n y Ciencia, Spain SAF2007-65957-C02-02, SAF2008-03871; from the Fondo de Investigaciones Sanitarias, RTICC RD06/0020/0107 and PI10/ 00621; from Fundacio´n Cientı´fica de la Asociacio´n Espan˜ola Contra el Ca´ncer (AECC). LDL is supported by a fellowship from Ministerio de Sanidad y Consumo (FI08/00038); NM is supported by a contract from Ministerio de Sanidad y Consumo (CP06/00002)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Reseña (Review)

CD30-positive primary cutaneous lymphoproliferative disorders: molecular alterations and targeted therapies

  • Prieto-Torres, L.
  • Rodriguez-Pinilla, S.M.
  • Onaindia, A.
  • Ara, M.
  • Requena, L.
  • Piris, M.Á.
Primary cutaneous CD30-positive T-cell lymphoproliferative disorders are the second most common subgroup of cutaneous T-cell lymphomas. They include two clinically different entities with some overlapping features and borderline cases: lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma. Molecular studies of primary cutaneous anaplastic large cell lymphoma reveal an increasing level of heterogeneity that is associated with histological and immunophenotypic features of the cases and their response to specific therapies. Here, we review the most significant genetic, epigenetic and molecular alterations described to date in primary cutaneous CD30-positive T-cell lymphoproliferative disorders, and their potential as therapeutic targets.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Two independent consecutive lymphoma cases carry an identical MYD88 mutation but differ in their IGVH rearrangement

  • Prieto-Torres, L
  • Trascasa, A
  • Manso, R
  • Machan, S
  • Cieza-Diaz, D
  • Olmedilla, G
  • Garcia-Garcia, M
  • Ara-Martin, M
  • Requena, L
  • Piris, MA
  • Rodriguez-Pinilla, SM
Several studies have provided evidence of the presence of lymphoma stem cells by showing the apparent transmission of premalignant lymphoid cells in allogeneic bone marrow transplantation, where the donor and recipient develop the same lymphoid disease.1-6 The lymphoid neoplasms do not develop at the same time, and in some cases, a different immunoglobulin heavy chain (IgH) rearrangement occurs in the two tumours. These data support the theory of a common lymphoma precursor cell (CPC) and make it less likely that it is due to a circulating donor tumour cell. Recently, Hattori et al.7 published genetic evidence of CPC in primary central nervous system diffuse large B-cell lymphoma (PCNS-DLBCL), suggesting that intra- and extra-CNS tumours in the same patient are derived from CPC with myeloid differentiation factor 88 (MYD88) L265P gene mutations, which arise before or after the IgH rearrangement. They suggested that CPC maps to different positions during B-lineage differentiation. The position after IgH rearrangement and even after hypermutation at the variable region could explain the appearance of clonally related lymphomas, whereas the emergence of CPC before IgH rearrangement might account for the presence of clonally unrelated B-cell lymphomas in the same patient because divergence may occur before the Variable-Diversity-Junctional (VDJ) rearrangements.